Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138525392> ?p ?o ?g. }
- W2138525392 abstract "Armodafinil is a wakefulness-promoting medication. Its efficacy and tolerability have been established in 12-week studies of patients with excessive sleepiness (ES) associated with treated obstructive sleep apnea (OSA), shift work disorder (SWD), or narcolepsy. This study evaluated the tolerability and efficacy of armodafinil for > or = 12 months.Patients with ES associated with treated OSA, SWD, or narcolepsy who completed one of four 12-week, double-blind studies were eligible for this multicenter, open-label study of > or = 12 months' duration of treatment with armodafinil (50 to 250 mg/day). Adverse events and other criteria of tolerability were monitored throughout the study. Efficacy assessments included the Clinical Global Impression of Change (CGI-C), Brief Fatigue Inventory (BFI), and Epworth Sleepiness Scale (ESS).Of 743 enrolled patients (474 with treated OSA, 113 with SWD, and 156 with narcolepsy), 57% of patients (420/743) completed 12 months or more of treatment. Discontinuations due to adverse events occurred in 13% of patients (95/743) during the initial 12-month period. Throughout the > or = 12-month study, adverse events were generally of mild-to-moderate intensity; headache (25% [180/731]), nasopharyngitis (17% [123/731]), and insomnia (14% [99/731]) were the most common. Modest increases were observed in vital sign measurements (blood pressure [3.6/2.3 mm Hg], heart rate [6.7 beats per minute]) across all patient groups; most of the changes occurred by month 3. Improvements from baseline in efficacy assessments started at month 1 and were maintained throughout the study.Armodafinil remained effective and was generally well tolerated. Increased monitoring of blood pressure may be appropriate in patients on armodafinil. Armodafinil represents an option for long-term treatment of patients with ES associated with treated OSA, SWD, or narcolepsy." @default.
- W2138525392 created "2016-06-24" @default.
- W2138525392 creator A5024396069 @default.
- W2138525392 creator A5044423592 @default.
- W2138525392 creator A5056094836 @default.
- W2138525392 creator A5057078715 @default.
- W2138525392 creator A5060470363 @default.
- W2138525392 date "2010-10-15" @default.
- W2138525392 modified "2023-09-24" @default.
- W2138525392 title "The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study." @default.
- W2138525392 cites W152319107 @default.
- W2138525392 cites W1544652607 @default.
- W2138525392 cites W1630205487 @default.
- W2138525392 cites W1701321738 @default.
- W2138525392 cites W194478883 @default.
- W2138525392 cites W1963566780 @default.
- W2138525392 cites W197066864 @default.
- W2138525392 cites W1975771352 @default.
- W2138525392 cites W2001038217 @default.
- W2138525392 cites W2048979642 @default.
- W2138525392 cites W2078986528 @default.
- W2138525392 cites W2100531908 @default.
- W2138525392 cites W2115020226 @default.
- W2138525392 cites W2124052130 @default.
- W2138525392 cites W2130120700 @default.
- W2138525392 cites W2136431713 @default.
- W2138525392 cites W2139704316 @default.
- W2138525392 cites W2155838990 @default.
- W2138525392 cites W2157191239 @default.
- W2138525392 cites W2157209201 @default.
- W2138525392 cites W2162920459 @default.
- W2138525392 cites W2333343699 @default.
- W2138525392 cites W2335449614 @default.
- W2138525392 cites W82338283 @default.
- W2138525392 cites W83603467 @default.
- W2138525392 cites W1536849423 @default.
- W2138525392 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2952749" @default.
- W2138525392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20957846" @default.
- W2138525392 hasPublicationYear "2010" @default.
- W2138525392 type Work @default.
- W2138525392 sameAs 2138525392 @default.
- W2138525392 citedByCount "23" @default.
- W2138525392 countsByYear W21385253922012 @default.
- W2138525392 countsByYear W21385253922013 @default.
- W2138525392 countsByYear W21385253922014 @default.
- W2138525392 countsByYear W21385253922015 @default.
- W2138525392 countsByYear W21385253922016 @default.
- W2138525392 countsByYear W21385253922017 @default.
- W2138525392 countsByYear W21385253922018 @default.
- W2138525392 countsByYear W21385253922020 @default.
- W2138525392 countsByYear W21385253922021 @default.
- W2138525392 countsByYear W21385253922023 @default.
- W2138525392 crossrefType "journal-article" @default.
- W2138525392 hasAuthorship W2138525392A5024396069 @default.
- W2138525392 hasAuthorship W2138525392A5044423592 @default.
- W2138525392 hasAuthorship W2138525392A5056094836 @default.
- W2138525392 hasAuthorship W2138525392A5057078715 @default.
- W2138525392 hasAuthorship W2138525392A5060470363 @default.
- W2138525392 hasConcept C118552586 @default.
- W2138525392 hasConcept C126322002 @default.
- W2138525392 hasConcept C1513209611 @default.
- W2138525392 hasConcept C187212893 @default.
- W2138525392 hasConcept C197934379 @default.
- W2138525392 hasConcept C2776006263 @default.
- W2138525392 hasConcept C2777935920 @default.
- W2138525392 hasConcept C2778205975 @default.
- W2138525392 hasConcept C2778375690 @default.
- W2138525392 hasConcept C2779034229 @default.
- W2138525392 hasConcept C2779494582 @default.
- W2138525392 hasConcept C2780714222 @default.
- W2138525392 hasConcept C2781210498 @default.
- W2138525392 hasConcept C2781326671 @default.
- W2138525392 hasConcept C2909718394 @default.
- W2138525392 hasConcept C42219234 @default.
- W2138525392 hasConcept C71924100 @default.
- W2138525392 hasConceptScore W2138525392C118552586 @default.
- W2138525392 hasConceptScore W2138525392C126322002 @default.
- W2138525392 hasConceptScore W2138525392C1513209611 @default.
- W2138525392 hasConceptScore W2138525392C187212893 @default.
- W2138525392 hasConceptScore W2138525392C197934379 @default.
- W2138525392 hasConceptScore W2138525392C2776006263 @default.
- W2138525392 hasConceptScore W2138525392C2777935920 @default.
- W2138525392 hasConceptScore W2138525392C2778205975 @default.
- W2138525392 hasConceptScore W2138525392C2778375690 @default.
- W2138525392 hasConceptScore W2138525392C2779034229 @default.
- W2138525392 hasConceptScore W2138525392C2779494582 @default.
- W2138525392 hasConceptScore W2138525392C2780714222 @default.
- W2138525392 hasConceptScore W2138525392C2781210498 @default.
- W2138525392 hasConceptScore W2138525392C2781326671 @default.
- W2138525392 hasConceptScore W2138525392C2909718394 @default.
- W2138525392 hasConceptScore W2138525392C42219234 @default.
- W2138525392 hasConceptScore W2138525392C71924100 @default.
- W2138525392 hasLocation W21385253921 @default.
- W2138525392 hasOpenAccess W2138525392 @default.
- W2138525392 hasPrimaryLocation W21385253921 @default.
- W2138525392 hasRelatedWork W1241659441 @default.
- W2138525392 hasRelatedWork W144263799 @default.
- W2138525392 hasRelatedWork W1480559618 @default.
- W2138525392 hasRelatedWork W1494899024 @default.
- W2138525392 hasRelatedWork W152319107 @default.